scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1092242652 |
P356 | DOI | 10.1186/S13287-017-0675-2 |
P932 | PMC publication ID | 5644064 |
P698 | PubMed publication ID | 29037258 |
P50 | author | Ienglam Lei | Q85370147 |
P2093 | author name string | Liu Liu | |
Zhong Wang | |||
Shuo Tian | |||
Shaoxiang Xian | |||
Mai T Lam | |||
Lingjun Wang | |||
Elizabeth M Meier | |||
P2860 | cites work | Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. | Q50669715 |
Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation. | Q50927720 | ||
Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction. | Q51019182 | ||
Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. | Q51355894 | ||
Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium. | Q51495604 | ||
Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. | Q53169787 | ||
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
Evaluation of the porcine intestinal collagen layer as a biomaterial | Q73953562 | ||
Chimerism of the transplanted heart | Q77452324 | ||
Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling | Q83323467 | ||
Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells | Q83688016 | ||
Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction | Q83697673 | ||
Engineering a novel three-dimensional contractile myocardial patch with cell sheets and decellularised matrix | Q83899496 | ||
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages | Q24310167 | ||
Evidence for cardiomyocyte renewal in humans | Q24594522 | ||
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network | Q26821783 | ||
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction | Q27334319 | ||
Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart | Q28190508 | ||
Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification | Q28275356 | ||
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications | Q28551325 | ||
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines | Q29616799 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart | Q33734834 | ||
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium | Q34114690 | ||
Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects | Q34363654 | ||
Characterization of printable cellular micro-fluidic channels for tissue engineering. | Q34796991 | ||
Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction | Q35694608 | ||
Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction | Q35754348 | ||
MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. | Q35892464 | ||
Porous nanofibrous poly(L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering | Q36096101 | ||
Effective delivery of stem cells using an extracellular matrix patch results in increased cell survival and proliferation and reduced scarring in skin wound healing | Q36593606 | ||
Origins and fates of cardiovascular progenitor cells | Q36828639 | ||
Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice | Q37733082 | ||
Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. | Q37947820 | ||
A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration. | Q38006734 | ||
Understanding roles of porcine small intestinal submucosa in urinary bladder regeneration: identification of variable regenerative characteristics of small intestinal submucosa | Q38115346 | ||
Cardiac regeneration: All work and no repair? | Q39207478 | ||
The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction | Q42080190 | ||
Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing | Q42377947 | ||
Cellular encapsulation enhances cardiac repair | Q42875580 | ||
Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice | Q45216514 | ||
Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. | Q45992110 | ||
The bladder acellular matrix graft in a rat chemical cystitis model: functional and histologic evaluation | Q46515843 | ||
Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials | Q46700937 | ||
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
P433 | issue | 1 | |
P304 | page(s) | 230 | |
P577 | publication date | 2017-10-16 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | Transplantation of Isl1+ cardiac progenitor cells in small intestinal submucosa improves infarcted heart function | |
P478 | volume | 8 |
Q88618933 | Cell therapy trials for heart regeneration - lessons learned and future directions |
Q93270635 | Gene therapy for cardiovascular diseases in China: basic research |
Q64892488 | HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction. |
Q90397440 | Identification and Functional Characterization of an ISL1 Mutation Predisposing to Dilated Cardiomyopathy |
Q92326034 | Main histological parameters to be evaluated in an experimental model of myocardial infarct treated by stem cells on pigs |
Q98465905 | Surface modification of small intestine submucosa in tissue engineering |
Q55118363 | Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair. |
Search more.